: Nonsteroidal antiinflammatory drugs (NSAIDs) are widely used in the treatment of chronic inflammatory states. In addition, they show promise for the prevention and therapy of colon cancers and of Alzheimer's disease, although their gastrointestinal toxicity is of concern for these indications. Nitric oxide-releasing NSAIDs are reported to be safer than their parent compounds. We report here that flurbiprofen nitroxybutyl ester inhibits nuclear factor-kappaB (NF-kappaB) activity and cell growth in L929 cells at a concentration of 100 microM, whereas flurbiprofen is inactive. Inhibition of cell growth is not due to the induction of apoptosis, but to a retardation of all phases of the cell cycle. NF-kappaB is implicated both in the control of immune and inflammatory response and in the control of cell proliferation and apoptosis. Therefore, its inhibition at low concentrations by an NSAID with low gastrointestinal toxicity could be important for all the above-mentioned therapeutic indications.
Inhibition of nuclear factor-kappaB by a nitro-derivative of flurbiprofen: a possible mechanism for antiinflammatory and antiproliferative effect
Ghezzi, Pietro
2003
Abstract
: Nonsteroidal antiinflammatory drugs (NSAIDs) are widely used in the treatment of chronic inflammatory states. In addition, they show promise for the prevention and therapy of colon cancers and of Alzheimer's disease, although their gastrointestinal toxicity is of concern for these indications. Nitric oxide-releasing NSAIDs are reported to be safer than their parent compounds. We report here that flurbiprofen nitroxybutyl ester inhibits nuclear factor-kappaB (NF-kappaB) activity and cell growth in L929 cells at a concentration of 100 microM, whereas flurbiprofen is inactive. Inhibition of cell growth is not due to the induction of apoptosis, but to a retardation of all phases of the cell cycle. NF-kappaB is implicated both in the control of immune and inflammatory response and in the control of cell proliferation and apoptosis. Therefore, its inhibition at low concentrations by an NSAID with low gastrointestinal toxicity could be important for all the above-mentioned therapeutic indications.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
